Manulife (Manufacturers Life Insurance)’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-67,981
| Closed | -$231K | – | 2931 |
|
|
2018
Q3 | $231K | Sell |
67,981
-9,104
| -12% | -$32.8K | ﹤0.01% | 2679 |
|
|
2018
Q2 | $290K | Buy |
77,085
+3,935
| +5% | +$19.2K | ﹤0.01% | 2816 |
|
|
2018
Q1 | $299K | Sell |
73,150
-2,029
| -3% | -$9.45K | ﹤0.01% | 2720 |
|
|
2017
Q4 | $349K | Buy |
75,179
+1,648
| +2% | +$9.08K | ﹤0.01% | 2578 |
|
|
2017
Q3 | $522K | Buy |
73,531
+7,370
| +11% | +$53K | ﹤0.01% | 2243 |
|
|
2017
Q2 | $477K | Buy |
66,161
+2,564
| +4% | +$16K | ﹤0.01% | 2330 |
|
|
2017
Q1 | $392K | Buy |
63,597
+7,638
| +14% | +$41.8K | ﹤0.01% | 2357 |
|
|
2016
Q4 | $328K | Sell |
55,959
-331
| -0.6% | -$1.81K | ﹤0.01% | 2411 |
|
|
2016
Q3 | $299K | Buy |
56,290
+109
| +0.2% | +$588 | ﹤0.01% | 2455 |
|
|
2016
Q2 | $372K | Sell |
56,181
-13,445
| -19% | -$75.2K | ﹤0.01% | 2228 |
|
|
2016
Q1 | $328K | Buy |
69,626
+860
| +1% | +$3.43K | ﹤0.01% | 2251 |
|
|
2015
Q4 | $348 | Hold |
68,766
| – | – | ﹤0.01% | 2263 |
|
|
2015
Q3 | $242 | Sell |
68,766
-210,254
| -75% | -$1.41M | ﹤0.01% | 2491 |
|
|
2015
Q2 | $2.79K | Sell |
279,020
-192
| -0.1% | -$2.06K | ﹤0.01% | 1326 |
|
|
2015
Q1 | $3.56K | Buy |
279,212
+48,895
| +21% | +$629K | ﹤0.01% | 1207 |
|
|
2014
Q4 | $3.26K | Sell |
230,317
-28,581
| -11% | -$443K | ﹤0.01% | 1181 |
|
|
2014
Q3 | $3.56K | Buy |
258,898
+10,263
| +4% | +$157K | 0.01% | 1151 |
|
|
2014
Q2 | $3.82M | Buy |
248,635
+182,208
| +274% | +$2.58M | 0.01% | 1128 |
|
|
2014
Q1 | $1.13K | Buy |
66,427
+4,539
| +7% | +$68.5K | ﹤0.01% | 1551 |
|
|
2013
Q4 | $801 | Buy |
61,888
+1,977
| +3% | +$23.6K | ﹤0.01% | 1745 |
|
|
2013
Q3 | $605 | Buy |
59,911
+998
| +2% | +$8.88K | ﹤0.01% | 1873 |
|
|
2013
Q2 | $440K | Buy |
+58,913
| New | +$460K | ﹤0.01% | 1978 |
|
Manulife (Manufacturers Life Insurance)'s KERX Position: Q4 2018 in Review
Manulife (Manufacturers Life Insurance) sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 67,981 shares — an estimated $231K sold.
Manulife (Manufacturers Life Insurance) first reported a position in KERX in Q2 2013 and held it in 22 quarters. The position peaked at $3.82M in Q2 2014. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.
- Manulife (Manufacturers Life Insurance) reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
- Manulife (Manufacturers Life Insurance) sold 67,981 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $231K.
- Manulife (Manufacturers Life Insurance) first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and held it in 22 quarters.
- Manulife (Manufacturers Life Insurance)'s Keryx Biopharmaceuticals Inc position peaked at $3.82M in Q2 2014.
- 1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2018, filed 14 Feb 2019.